fulvestrant has been researched along with edetic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chaudhuri, G; Esaki, T; Hayashi, T; Iguchi, A; Muto, E; Yamada, K | 1 |
1 review(s) available for fulvestrant and edetic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for fulvestrant and edetic acid
| Article | Year |
|---|---|
Physiological concentrations of 17beta-estradiol inhibit the synthesis of nitric oxide synthase in macrophages via a receptor-mediated system.
Topics: Animals; Antibodies, Monoclonal; Blotting, Western; Cell Line; Edetic Acid; Estradiol; Estrogen Antagonists; Fulvestrant; Immunohistochemistry; Interferon-gamma; Lipopolysaccharides; Macrophages; Mice; Microelectrodes; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Tamoxifen | 1998 |